163 related articles for article (PubMed ID: 12137811)
1. Update on pathologic staging of renal cell carcinoma.
Gettman MT; Blute ML
Urology; 2002 Aug; 60(2):209-17. PubMed ID: 12137811
[No Abstract] [Full Text] [Related]
2. Staging and survival of patients with renal cell carcinoma.
Guinan P; Frank W; Saffrin R; Rubenstein M
Semin Surg Oncol; 1994; 10(1):47-50. PubMed ID: 8115785
[TBL] [Abstract][Full Text] [Related]
3. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
Ficarra V; Novara G; Martignoni G
Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
[No Abstract] [Full Text] [Related]
4. Prognostic factors in renal cell cancer.
Park WH; Eisen T
BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
[No Abstract] [Full Text] [Related]
5. Prognostic factors in localized renal cell cancer.
Knight DA; Stadler WM
BJU Int; 2007 May; 99(5 Pt B):1212-6. PubMed ID: 17441913
[No Abstract] [Full Text] [Related]
6. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI
Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980
[TBL] [Abstract][Full Text] [Related]
7. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?
Waalkes S; Becker F; Schrader AJ; Janssen M; Wegener G; Merseburger AS; Schrader M; Hofmann R; Stöckle M; Kuczyk MA
Eur Urol; 2011 Feb; 59(2):258-63. PubMed ID: 21030143
[TBL] [Abstract][Full Text] [Related]
8. Validation of the ucla integrated staging system for patients with renal cell carcinoma.
Zisman A; Pantuck AJ; Figlin RA; Belldegrun AS
J Clin Oncol; 2001 Sep; 19(17):3792-3. PubMed ID: 11533107
[No Abstract] [Full Text] [Related]
9. Editorial comment.
Pomara G; Francesca F
Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
[No Abstract] [Full Text] [Related]
10. [A study on the relationship between pathologic morphology and clinical prognosis of renal cell carcinoma].
Wen B; Hang Z; Wei Y
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Sep; 23(3):332-4. PubMed ID: 1298729
[TBL] [Abstract][Full Text] [Related]
11. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort.
Kim SP; Alt AL; Weight CJ; Costello BA; Cheville JC; Lohse C; Allmer C; Leibovich BC
J Urol; 2011 Jun; 185(6):2035-9. PubMed ID: 21496854
[TBL] [Abstract][Full Text] [Related]
12. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
13. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
[TBL] [Abstract][Full Text] [Related]
14. Impact of histologic subtyping of renal epithelial neoplasms.
Vollmer RT
Am J Surg Pathol; 2003 Jul; 27(7):1021-2; author reply 1022-4. PubMed ID: 12826898
[No Abstract] [Full Text] [Related]
15. Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.
Hong SK; Jeong CW; Park JH; Kim HS; Kwak C; Choe G; Kim HH; Lee SE
BJU Int; 2011 Feb; 107(3):409-15. PubMed ID: 20804473
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma: vena caval involvement.
Boorjian SA; Sengupta S; Blute ML
BJU Int; 2007 May; 99(5 Pt B):1239-44. PubMed ID: 17441917
[No Abstract] [Full Text] [Related]
17. Renal tumours: the new order.
Delahunt B; Eble JN
N Z Med J; 1998 Aug; 111(1072):307-9. PubMed ID: 9765626
[No Abstract] [Full Text] [Related]
18. Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy.
Weight CJ; Lythgoe C; Unnikrishnan R; Lane BR; Campbell SC; Fergany AF
Urology; 2011 May; 77(5):1142-6. PubMed ID: 21420154
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
Billis A
Int Braz J Urol; 2004; 30(4):347-8. PubMed ID: 15679982
[No Abstract] [Full Text] [Related]
20. Editorial comment.
Russo P
Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
